Scientific Industries, Inc.
SCND
$1.06
$0.010.95%
| Weiss Ratings | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.53 | |||
| Price History | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.92% | |||
| 30-Day Total Return | 2.66% | |||
| 60-Day Total Return | 0.95% | |||
| 90-Day Total Return | -14.52% | |||
| Year to Date Total Return | 6.00% | |||
| 1-Year Total Return | -40.78% | |||
| 2-Year Total Return | -79.42% | |||
| 3-Year Total Return | -83.04% | |||
| 5-Year Total Return | -89.90% | |||
| 52-Week High % Change | -52.89% | |||
| 52-Week Low % Change | 482.42% | |||
| Price | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.25 | |||
| 52-Week Low Price | $0.18 | |||
| 52-Week Low Price (Date) | Apr 09, 2024 | |||
| 52-Week High Price (Date) | Jul 29, 2024 | |||
| Valuation | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 11.13M | |||
| Enterprise Value | 9.20M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.74 | |||
| Earnings Per Share Growth | -43.87% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.05 | |||
| Price/Book (Q) | 1.02 | |||
| Enterprise Value/Revenue (TTM) | 0.86 | |||
| Price | $1.06 | |||
| Enterprise Value/EBITDA (TTM) | -1.47 | |||
| Enterprise Value/EBIT | -1.31 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 10.50M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.05 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $0.05 | |||
| Company Info | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 631 567 4700 | |||
| Address | 80 Orville Drive Bohemia, NY 11716 | |||
| Website | www.scientificindustries.com | |||
| Country | United States | |||
| Year Founded | 1954 | |||
| Profitability | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -66.03% | |||
| Profit Margin | -63.34% | |||
| Management Effectiveness | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -33.32% | |||
| Return on Equity | -- | |||
| Income Statement | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 10.64M | |||
| Total Revenue (TTM) | 10.64M | |||
| Revenue Per Share | $1.01 | |||
| Gross Profit (TTM) | 4.93M | |||
| EBITDA (TTM) | -6.27M | |||
| EBIT (TTM) | -7.03M | |||
| Net Income (TTM) | -6.74M | |||
| Net Income Avl. to Common (TTM) | -6.74M | |||
| Total Revenue Growth (Q YOY) | 7.10% | |||
| Earnings Growth (Q YOY) | 46.39% | |||
| EPS Diluted (TTM) | -0.74 | |||
| EPS Diluted Growth (Q YOY) | 64.24% | |||
| Balance Sheet | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.03M | |||
| Cash Per Share (Q) | $0.29 | |||
| Total Current Assets (Q) | 9.65M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 10.93M | |||
| Current Ratio (Q) | 5.993 | |||
| Book Value Per Share (Q) | $1.04 | |||
| Total Assets (Q) | 13.31M | |||
| Total Current Liabilities (Q) | 1.61M | |||
| Total Debt (Q) | 1.09M | |||
| Total Liabilities (Q) | 2.37M | |||
| Total Common Equity (Q) | 10.93M | |||
| Cash Flow | SCND - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.71M | |||
| Cash from Financing (TTM) | 6.38M | |||
| Net Change in Cash (TTM) | 48.10K | |||
| Levered Free Cash Flow (TTM) | -3.34M | |||
| Cash from Operations (TTM) | -4.64M | |||
